Thursday, December 14, 2017 2:51:10 PM
I tried very hard to have Fidelity review SGMD and it's potential and low risk, as well as the current filing issues, but Fidelity has a policy that can't be individually reviewed on a case by case basis for companies. SGMD must become current with OTC for Fidelity to enable buying, as the manager has told me over the phone. He did say, however that if buying isn't working immediately after the company becomes current, a phone call will be all that's needed to code the ticker to trade. He seemed to be only about 80% sure (in my opinion, 80-90% sure) that SGMD will automatically be enabled for trading.
x100xPercent
Recent SGMD News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 08:54:54 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM